XEDAR activators belong to a distinctive chemical class characterized by their ability to modulate the XEDAR signaling pathway. XEDAR, or X-linked ectodysplasin-A receptor, is a transmembrane protein receptor that plays a crucial role in various cellular processes, particularly those related to immune responses and developmental pathways. The activators of this class exert their effects by binding to specific sites on the XEDAR receptor, triggering a cascade of intracellular events. These small molecules act as agonists, promoting the activation of XEDAR and subsequently influencing downstream signaling pathways.
Structurally, XEDAR activators typically possess a set of chemical features that enable them to interact selectively with the XEDAR receptor. The binding of these activators induces conformational changes in the receptor, leading to the initiation of cellular responses. The specificity of XEDAR activators distinguishes them from other compounds that may interact with related receptors, emphasizing their potential as tools for studying the intricate molecular mechanisms associated with the XEDAR signaling pathway. The exploration of XEDAR activators in various experimental contexts provides valuable insights into the physiological functions regulated by this pathway, paving the way for a deeper understanding of cellular processes and potential implications for future research endeavors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MCI-186 | 89-25-8 | sc-200806 sc-200806A | 5 g 100 g | $20.00 $32.00 | 10 | |
An antioxidant that may activate signaling pathways related to oxidative stress, potentially enhancing the activation of the XEDAR receptor. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An NF-kappa B inhibitor that may have downstream effects on XEDAR receptor activation by modulating the nuclear factor-kappa B pathway. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
A compound affecting Wnt signaling pathways, potentially activating the XEDAR receptor through its interaction with Wnt pathways. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
A Hedgehog pathway inhibitor that may have downstream activating effects on XEDAR receptor by modulating the Hedgehog signaling pathway. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $75.00 $121.00 | 33 | |
An EGFR inhibitor that may indirectly affect XEDAR receptor activation by modulating the epidermal growth factor receptor pathway. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A Notch signaling modulator that may have downstream activating effects on pathways connected to XEDAR receptor activation through its interaction with Notch signaling. | ||||||